Multi-institutional analysis of aneuploidy and outcomes to chemoradiation and durvalumab in stage III non-small cell lung cancer

There is a need to identify predictive biomarkers to guide treatment strategies in stage III non-small cell lung cancer (NSCLCs). In this multi-institutional cohort of 197 patients with stage III NSCLC treated with concurrent chemoradiation (cCRT) and durvalumab consolidation, we identify that low t...

Descripción completa

Detalles Bibliográficos
Autores principales: Alessi, Joao V, Price, Adam, Richards, Allison L, Ricciuti, Biagio, Wang, Xinan, Elkrief, Arielle, Pecci, Federica, Di Federico, Alessandro, Gandhi, Malini M, Lebow, Emily S, Santos, Patricia Mae G, Thor, Maria, Rimner, Andreas, Schoenfeld, Adam J, Chaft, Jamie E, Johnson, Bruce E, Gomez, Daniel R, Awad, Mark M, Shaverdian, Narek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Immunotherapy Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626762/
https://www.ncbi.nlm.nih.gov/pubmed/37914383
http://dx.doi.org/10.1136/jitc-2023-007618

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626762/
https://www.ncbi.nlm.nih.gov/pubmed/37914383
http://dx.doi.org/10.1136/jitc-2023-007618

Ejemplares similares